|
|
|
Corporate Profile:
Amarin
| Summary: |
| Amarin is focused on the development of small molecule lipophillic drugs for the treatment of cardiovascular disease. |
| Address (US HQ): |
1430 Route 206
Suite 200
Bedminster, NJ 07921 |
| Phone #'s (US HQ): |
| Main |
(908) 719-1315 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (US HQ): |
| Main |
(908) 719-3012 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| AMRN |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
